Direct Answer: Bone Marrow Aspirate Concentrate (BMAC) is a treatment that uses a small sample of a patient's own bone marrow — typically drawn from the pelvis — which is then concentrated in a centrifuge and injected into an area of injury or degeneration. Because it uses the patient's own (autologous) cells, BMAC is regulated differently than commercial donor-tissue "stem cell" products, and it's one of the treatments now detailed on the practice's new BMAC page.
What This Means for You
BMAC concentrates a mix of cells naturally found in bone marrow, including mesenchymal stem cells, growth factors, and other supportive cellular material, into a small, injectable volume. It's performed as an outpatient, same-day procedure: the marrow is drawn, processed in-office, and injected the same visit. It's most often considered for joint conditions where PRP alone may be insufficient, though candidacy depends on the specific condition and a full evaluation.
Dr. Tortland's Perspective
BMAC is one of the treatments I get asked about most, often by patients who've already tried PRP or are trying to avoid surgery. I've put together a full page walking through candidacy, the procedure itself, recovery, and the regulatory framework we operate under — including FDA / 21 CFR Part 1271 compliance, since that's an area with a lot of misinformation. I'd encourage anyone considering this to read that page in full before a consultation, so we can spend our time together on your specific situation rather than the basics.